{"id":11367,"date":"2025-07-30T07:33:41","date_gmt":"2025-07-30T07:33:41","guid":{"rendered":"https:\/\/mdxcro.com\/therapeutic-areas\/"},"modified":"2026-07-23T12:16:26","modified_gmt":"2026-07-23T12:16:26","slug":"domaines-therapeutiques","status":"publish","type":"page","link":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/","title":{"rendered":"Aires th\u00e9rapeutiques"},"content":{"rendered":"\n<section id=\"block_4f65dd18384948195e7d98c5bb0e4251\" class=\"hero\">\n    <div class=\"hero--bg\">\n      <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2026\/04\/therapeutic-areas-MDx-CRO-1.webp\" fetchpriority=\"high\" class=\"no-lazy\" alt=\"\" \/>\n    <\/div>\n        <div class=\"container\">\n                <div class=\"content\">\n                                    <h1 class=\"title\">Services CRO pour les IVD et les dispositifs m\u00e9dicaux par domaine th\u00e9rapeutique<\/h1>\n            \n                            <div class=\"description\"><p><span style=\"font-weight: 400;\">Un accompagnement sp\u00e9cialis\u00e9 pour les essais cliniques de DMIVD et de dispositifs m\u00e9dicaux en oncologie, maladies infectieuses, g\u00e9n\u00e9tique et m\u00e9decine cardiovasculaire. Acc\u00e9l\u00e9rez les autorisations gr\u00e2ce \u00e0 des strat\u00e9gies r\u00e9glementaires et cliniques sp\u00e9cifiques \u00e0 chaque aire th\u00e9rapeutique. <\/span><\/p>\n<\/div>\n            \n                            <div class=\"button-wrapper\">\n                                            <a href=\"https:\/\/mdxcro.com\/fr\/contact\/?utm_source=terapeutic_areas\" class=\"button button--default\" target=\"_self\">\n                            R\u00e9server un appel de d\u00e9couverte                        <\/a>\n                                    <\/div>\n                            <\/div>\n            <\/div>\n<\/section>\n\n\n\n<section id=\"block_cfc7ec82e861ba97c2449144750d225a\" class=\"sticky-navbar\" style=\"\">\n                <div class=\"container\">\n                <ul class=\"list\">\n                    <li class=\"item\">\n                            <a href=\"#overview\" class=\"link\" target=\"\"> \n                    Aper\u00e7u \n                <\/a>\n                                <li class=\"item\">\n                            <a href=\"#ivds\" class=\"link\" target=\"\"> \n                    DMIVD \n                <\/a>\n                                <li class=\"item\">\n                            <a href=\"#Precision-Medicine\" class=\"link\" target=\"\"> \n                    M\u00e9decine de pr\u00e9cision \n                <\/a>\n                                <li class=\"item\">\n                            <a href=\"#MedicalDevices\" class=\"link\" target=\"\"> \n                    Dispositifs m\u00e9dicaux \n                <\/a>\n                            <\/ul>\n                \n    <\/div>\n<\/section>\n\n\n\n<section id=\"overview\" class=\"text-image text-image--grayscale\" style=\"margin-top: var(--wp--preset--spacing--medium); margin-bottom: var(--wp--preset--spacing--medium); \">\n        <div class=\"container\">\n        <div class=\"grid\">\n            <div class=\"column column--content\"><div class=\"text\"><h2 class=\"title\">Expertise strat\u00e9gique par aire th\u00e9rapeutique<\/h2><div class=\"description wysiwyg\"><p><span style=\"font-weight: 400\">Chez MDx, nous sommes sp\u00e9cialis\u00e9s dans la fourniture de services r\u00e9glementaires et de recherche clinique dans divers domaines th\u00e9rapeutiques. Nous savons que chaque aire th\u00e9rapeutique pr\u00e9sente ses propres d\u00e9fis scientifiques, cliniques et r\u00e9glementaires. C\u2019est pourquoi notre approche repose sur des strat\u00e9gies sp\u00e9cifiques \u00e0 l\u2019aire th\u00e9rapeutique, con\u00e7ues pour r\u00e9pondre aux exigences complexes des diagnostics et dispositifs m\u00e9dicaux \u00e0 haut risque.  <\/span><\/p>\n<p><span style=\"font-weight: 400\">Que vous d\u00e9veloppiez un DM-IVD pour la surveillance des maladies infectieuses, un implant cardiovasculaire de classe III ou un diagnostic compagnon (CDx) de nouvelle g\u00e9n\u00e9ration, MDx garantit une navigation r\u00e9glementaire pr\u00e9cise et une ex\u00e9cution clinique efficace.<\/span><\/p>\n<\/div><\/div><\/div>                            <div class=\"column column--image\"><img decoding=\"async\" class=\"image\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/09\/strategic-scaled.jpeg\" alt=\"Innovative scientist working in a laboratory with microscope, test tubes, and chemical bottles, promoting MDX MedTech solutions for healthcare and medical technology innovation.\"  \/><\/div>                    <\/div>\n    <\/div>\n<\/section>\n\n\n\n<section id=\"ivds\" class=\"content-columns content-columns--three-columns \" style=\"padding-bottom: var(--wp--preset--spacing--small); \">\n        <div class=\"container\">\n                    <div class=\"content\">\n                                    <h2 class=\"title\">Expertise DM-IVD dans les principales aires th\u00e9rapeutiques<\/h2>\n                                            <\/div>\n        \n                    <div class=\"grid\">\n                                                        <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Maladies infectieuses &#038; immunit\u00e9<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><p>Avec plus de 35,8 % de notre portefeuille DM-IVD d\u00e9di\u00e9 aux diagnostics des maladies infectieuses, MDx est un partenaire de confiance pour :<\/p>\n<ul>\n<li>Tests mol\u00e9culaires (PCR, qPCR, panels multiplex)<\/li>\n<li>Validation s\u00e9rologique et des immunodosages<\/li>\n<li>Outils de RAM (r\u00e9sistance aux antimicrobiens) et de surveillance<\/li>\n<li>POCT pour la d\u00e9tection rapide d\u2019agents pathog\u00e8nes viraux\/bact\u00e9riens\/fongiques<\/li>\n<li>Panels respiratoires pour les tests syndromiques (p. ex., COVID-19, VRS, grippe)<\/li>\n<li>Mod\u00e8les de tests centralis\u00e9s et d\u00e9centralis\u00e9s sous IVDR<\/li>\n<li>Biobanque et gestion du cycle de vie des \u00e9chantillons<\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                <div class=\"bottom\">\n                          <p class=\"result\">\u00c9tude de cas<\/p>\n                          <p class=\"text\">Un fabricant mondial menant une \u00e9tude IVDR sur un DM-IVD PCR respiratoire s\u2019est associ\u00e9 \u00e0 MDx. Nous avons inclus des patients sur 8 sites de l\u2019UE, obtenant une inclusion pr\u00e9coce et une conformit\u00e9 des donn\u00e9es de 100 %. <\/p>\n                        <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Tests g\u00e9n\u00e9tiques &#038; g\u00e9nomiques<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><p>MDx accompagne 21,3 % des projets en diagnostics h\u00e9r\u00e9ditaires et g\u00e9nomiques, notamment :<\/p>\n<ul>\n<li>S\u00e9quen\u00e7age de l\u2019exome entier (WES), panels de g\u00e8nes cibl\u00e9s<\/li>\n<li>D\u00e9pistage des porteurs (\u00e9tendu, sp\u00e9cifique \u00e0 certaines origines ethniques)<\/li>\n<li>D\u00e9pistage pr\u00e9natal non invasif (NIPT)<\/li>\n<li>Diagnostics des maladies rares et \u00e9tudes sur petites populations<\/li>\n<li>Cytog\u00e9n\u00e9tique, MLPA et analyse SNV\/indels<\/li>\n<li>Validation des pipelines bioinformatiques et standards d\u2019annotation<\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                <div class=\"bottom\">\n                          <p class=\"result\">Point fort<\/p>\n                          <p class=\"text\">Nous avons accompagn\u00e9 un laboratoire am\u00e9ricain pour le marquage CE d\u2019un panel NGS de plus de 4\u202f000 g\u00e8nes, incluant le dossier technique complet, la conformit\u00e9 IVDR et la mise en place du syst\u00e8me ISO 13485.<br \/>\r\n<\/p>\n                        <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Marqueurs cardiovasculaires &#038; physiologiques<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><p>Plusieurs \u00e9tudes DM-IVD &#038; projets r\u00e9glementaires ax\u00e9s sur les diagnostics cardiom\u00e9taboliques :<\/p>\n<ul>\n<li>Biomarqueurs cardiaques (troponines, BNP, D-dim\u00e8res)<\/li>\n<li>Tests de coagulation et d\u2019h\u00e9mostase<\/li>\n<li>Panels lipidiques, HbA1c et m\u00e9taboliques<\/li>\n<li>POCT pour l\u2019\u00e9valuation cardiovasculaire en urgence<\/li>\n<li>Plateformes de tests du risque d\u2019AVC et de thrombose<\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                <div class=\"bottom\">\n                          <p class=\"result\">Exemple<\/p>\n                          <p class=\"text\">Accompagnement de la validation et de l\u2019\u00e9tude de performance clinique d\u2019un panel cardiaque POCT multi-marqueurs dans des centres de l\u2019UE, avec des environnements de flux de travail variables.<br \/>\r\n<\/p>\n                        <\/div>\n                                                                    <\/div>\n                                                <\/div>\n                  \n          \n\n            <\/div>\n<\/section>\n\n\n\n<section id=\"block_6c4ff41f58ddfbb9f72c4dad50a8415a\" class=\"flip-cards flip-cards--three-columns flip-cards--card-size-small \" style=\"padding-top: var(--wp--preset--spacing--small); padding-bottom: var(--wp--preset--spacing--regular); \">\n            <div class=\"container\">\n        <div class=\"content\">\n                            <h3 class=\"subtitle\">Autres domaines th\u00e9rapeutiques DM-IVD<\/h3>\n            \n            \n            \n                    <\/div>\n\n                    <div class=\"grid\">\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Neurologie &amp; neurod\u00e9g\u00e9n\u00e9rescence<\/div>\n                        <div class=\"back\"><p>Biomarqueurs d\u2019Alzheimer, outils d\u2019aide \u00e0 la neuro-imagerie, \u00e9valuations des fonctions cognitives<\/p>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Endocrinologie &amp; troubles m\u00e9taboliques<\/div>\n                        <div class=\"back\"><p>Panels thyro\u00efdiens, tests hormonaux, d\u00e9pistage du diab\u00e8te<\/p>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Sant\u00e9 des femmes<\/div>\n                        <div class=\"back\"><p>Diagnostics de fertilit\u00e9, suivi hormonal, d\u00e9pistage pr\u00e9natal<\/p>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Troubles auto-immuns &amp; inflammatoires<\/div>\n                        <div class=\"back\"><p>Panels d\u2019auto-anticorps, tests de r\u00e9ponse aux cytokines<\/p>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">M\u00e9decine de la transplantation<\/div>\n                        <div class=\"back\"><p>Typage HLA, tests de compatibilit\u00e9 donneur, surveillance du rejet de greffe<\/p>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">H\u00e9matologie &amp; m\u00e9decine transfusionnelle<\/div>\n                        <div class=\"back\"><p>Panels NFS, compatibilit\u00e9 transfusionnelle, surveillance de la s\u00e9curit\u00e9<\/p>\n<\/div>\n                    <\/div>\n                            <\/div>\n        \n            <\/div>\n<\/section>\n\n\n<section id=\"Precision-Medicine\" class=\"text-image text-image--reverse\" style=\"\">\n        <div class=\"container\">\n        <div class=\"grid\">\n            <div class=\"column column--content\"><div class=\"text\"><div class=\"description wysiwyg\"><p><b>Oncologie &#038; m\u00e9decine de pr\u00e9cision<\/b><\/p>\n<p><span style=\"font-weight: 400\">Les projets d\u2019oncologie et de CDx repr\u00e9sentent 25,5 % de notre activit\u00e9 DM-IVD. Nos services cliniques et r\u00e9glementaires int\u00e9gr\u00e9s incluent : <\/span><\/p>\n<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Profilage tumoral NGS et panels de mutations cibl\u00e9es<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">D\u00e9veloppement de CDx conform\u00e9ment \u00e0 l\u2019annexe XIV de l\u2019IVDR et aux lignes directrices de co-d\u00e9veloppement de la FDA<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Biopsie liquide (ctDNA, CTC) et d\u00e9tection de la MRD<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Scorage tissulaire IHC\/ISH et standardisation<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Diagnostics multimodaux int\u00e9grant la pathologie num\u00e9rique et les donn\u00e9es mol\u00e9culaires<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Strat\u00e9gie r\u00e9glementaire pour l\u2019alignement EMA\u2013FDA\u2013organisme notifi\u00e9<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div>                            <div class=\"column column--image\"><img decoding=\"async\" class=\"image\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/9bcfa81f4da5af9a789e8d5503d61fa0249200ba.jpg\" alt=\"Precise woman researcher examining biological sample using microscope in a laboratory, representing innovative MedTech developments.\"  \/><\/div>                    <\/div>\n    <\/div>\n<\/section>\n\n\n\n<section id=\"MedicalDevices\" class=\"flip-cards flip-cards--three-columns flip-cards--bg-blue\" style=\"\">\n            <div class=\"container\">\n        <div class=\"content\">\n            \n                            <h2 class=\"title\">Expertise dispositifs m\u00e9dicaux par aire th\u00e9rapeutique<\/h2>\n            \n            \n                    <\/div>\n\n                    <div class=\"grid\">\n                                    <div class=\"card card--background-white-frost\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Dispositifs cardiovasculaires &amp; implantables<\/div>\n                        <div class=\"back\"><ul>\n<li>Stents vasculaires, valves cardiaques, syst\u00e8mes de surveillance de classe III<\/li>\n<li>T\u00e9l\u00e9m\u00e9trie \u00e0 distance &#038; syst\u00e8mes portables de t\u00e9l\u00e9surveillance des patients (RPM)<\/li>\n<li>Dossiers UE MDR &#038; FDA classe III avec planification PMCF<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Dentaire, ORL (oto-rhino-laryngologie) &amp; sant\u00e9 auditive<\/div>\n                        <div class=\"back\"><ul>\n<li>Implants dentaires, guides chirurgicaux, scanners intra-oraux<\/li>\n<li>Diagnostics ORL, implants cochl\u00e9aires, plateformes d\u2019audiom\u00e9trie<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white-frost\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Neurotechnologies &amp; sant\u00e9 c\u00e9r\u00e9brale<\/div>\n                        <div class=\"back\"><ul>\n<li>Syst\u00e8mes de stimulation c\u00e9r\u00e9brale profonde (DBS), stimulation magn\u00e9tique transcr\u00e2nienne (TMS), stimulation transcr\u00e2nienne \u00e0 courant direct (tDCS)<\/li>\n<li>Logiciels neurologiques avec algorithmes de scoring am\u00e9lior\u00e9s par l\u2019IA<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white-frost\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Imagerie, navigation &amp; chirurgie<\/div>\n                        <div class=\"back\"><ul>\n<li>Tomographie par coh\u00e9rence optique (OCT), \u00e9chographie et dispositifs compatibles avec l\u2019imagerie par r\u00e9sonance magn\u00e9tique (IRM)<\/li>\n<li>Navigation chirurgicale, robotique guid\u00e9e par l\u2019image, syst\u00e8mes endoscopiques<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Respiratoire &amp; soins critiques<\/div>\n                        <div class=\"back\"><ul>\n<li>Dispositifs d\u2019oxyg\u00e9noth\u00e9rapie, n\u00e9buliseurs, moniteurs de fonction pulmonaire<\/li>\n<li>Syst\u00e8mes de th\u00e9rapie par pression n\u00e9gative (NPWT) et diagnostics de soins des plaies<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-black\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Sant\u00e9 num\u00e9rique &amp; SaMD<\/div>\n                        <div class=\"back\"><ul>\n<li>Th\u00e9rapeutiques num\u00e9riques, plateformes SaMD, syst\u00e8mes d\u2019aide \u00e0 la d\u00e9cision clinique (CDSS)<\/li>\n<li>Applications mobiles, validation de la cybers\u00e9curit\u00e9, conformit\u00e9 MDR des MDSW<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white-frost\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Dispositifs orthop\u00e9diques &amp; musculo-squelettiques<\/div>\n                        <div class=\"back\"><ul>\n<li>Syst\u00e8mes de remplacement articulaire, implants rachidiens, dispositifs de fixation<\/li>\n<li>Implants de classe IIb\/III n\u00e9cessitant un PMCF et une documentation technique<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Ophtalmologie &amp; soins de la vision<\/div>\n                        <div class=\"back\"><ul>\n<li>Lentilles intraoculaires, dispositifs OCT, scanners r\u00e9tiniens<\/li>\n<li>Tests d\u2019utilisabilit\u00e9 et \u00e9valuations de performance bas\u00e9es sur l\u2019image<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white-frost\"\n                                                  >\n                        \n                                                                            \n                        <div class=\"front\">Dispositifs pour le diab\u00e8te &amp; la sant\u00e9 m\u00e9tabolique<\/div>\n                        <div class=\"back\"><ul>\n<li>Capteurs de glucose en continu (CGM), syst\u00e8mes d\u2019administration d\u2019insuline<\/li>\n<li>Plateformes num\u00e9riques int\u00e9gr\u00e9es et gestion des risques pour les dispositifs combin\u00e9s<\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                            <\/div>\n        \n            <\/div>\n<\/section>\n\n\n<section id=\"block_7feaa6dc53dfcb4b72b9f08b57e5e80b\" class=\"charts\" style=\"padding-top: Par d\u00e9faut; padding-bottom: Par d\u00e9faut; margin-top: Par d\u00e9faut; margin-bottom: Par d\u00e9faut; \">\n  \t<div \n\t\tclass=\"component-top-icon\"\n\t\tstyle=\"--component-top-icon-height: 70px\"\n\t>\n\t\t<img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/mdx-logo.svg\" alt=\"\" \/>\n\t<\/div>\n\t  <div class=\"container\">\n\t\t  <h2 class=\"headline\">R\u00e9partition par aire th\u00e9rapeutique <\/h2>\n\t\n\t\t  \t\t<h3 class=\"subtitle\">Diagnostics<\/h3>\n\t  \n\t  <div class=\"grid\">\n\t\t\t\t  <div\n\t\t\tclass=\"chart\"\n\t\t\tdata-chart=\"anneau\"\n\t\t\tdata-colors=\"#0000f0, #2c59d9, #05a1b3, #8eebe1, #79c4bd\"\n\t\t\tdata-values=\"35.8, 25.5, 21.3, 9.2, 8.2\"\n\t\t\tdata-labels=\"Infection\/Immunit\u00e9, CDx, tests g\u00e9n\u00e9tiques, marqueurs physiologiques, autres\"\n\t\t\tdata-legend=\"true\">\n\t\t\t<canvas><\/canvas>\n\t\t  <\/div>\n\t\t\t\t  <div\n\t\t\tclass=\"chart\"\n\t\t\tdata-chart=\"anneau\"\n\t\t\tdata-colors=\"#0000f0, #2c59d9, #05a1b3\"\n\t\t\tdata-values=\"85, 11, 4\"\n\t\t\tdata-labels=\"Classe C, classe B, classe D\"\n\t\t\tdata-legend=\"true\">\n\t\t\t<canvas><\/canvas>\n\t\t  <\/div>\n\t\t\t  <\/div>\n\t\t  \t\t<h3 class=\"subtitle\">Dispositifs m\u00e9dicaux<\/h3>\n\t  \n\t  <div class=\"grid\">\n\t\t\t\t  <div\n\t\t\tclass=\"chart\"\n\t\t\tdata-chart=\"anneau\"\n\t\t\tdata-colors=\"#0000f0, #2c59d9, #05a1b3, #8eebe1\"\n\t\t\tdata-values=\"62.5, 19.3, 8, 10.2\"\n\t\t\tdata-labels=\"Implantable, g\u00e9n\u00e9ral, implantable actif, actif\"\n\t\t\tdata-legend=\"true\">\n\t\t\t<canvas><\/canvas>\n\t\t  <\/div>\n\t\t\t\t  <div\n\t\t\tclass=\"chart\"\n\t\t\tdata-chart=\"anneau\"\n\t\t\tdata-colors=\"#0000f0, #2c59d9, #05a1b3\"\n\t\t\tdata-values=\"29.6, 29.6, 40.8\"\n\t\t\tdata-labels=\"Classe III, classe IIb, classe IIa\"\n\t\t\tdata-legend=\"true\">\n\t\t\t<canvas><\/canvas>\n\t\t  <\/div>\n\t\t\t  <\/div>\n\t  <\/div>\n<\/section>\n\n\n<section id=\"block_0b6d846647bb82cad0ae5fa0b7bed1db\" class=\"content-columns content-columns--three-columns \" style=\"\">\n        <div class=\"container\">\n                    <div class=\"content\">\n                                    <h2 class=\"title\">Services int\u00e9gr\u00e9s d\u2019accompagnement th\u00e9rapeutique<\/h2>\n                                            <\/div>\n        \n                    <div class=\"grid\">\n                                                        <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Strat\u00e9gie clinique &#038; r\u00e9glementaire<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Conception de protocoles fond\u00e9e sur les standards propres \u00e0 l\u2019indication et le parcours patient<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">R\u00e9seaux de sites et de KOL optimis\u00e9s par domaine th\u00e9rapeutique<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Strat\u00e9gie de soumission int\u00e9grant les recommandations de la FDA, de l\u2019EMA et de l\u2019IVDR<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">G\u00e9n\u00e9ration de preuves align\u00e9e sur les attentes cliniques du domaine th\u00e9rapeutique<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Affaires m\u00e9dicales &#038; scientifiques<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Justification des crit\u00e8res d\u2019\u00e9valuation sp\u00e9cifiques au domaine th\u00e9rapeutique et revue de la litt\u00e9rature<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">R\u00e9daction m\u00e9dicale par des experts du domaine<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Soutien de comit\u00e9s scientifiques consultatifs et conseil en validation de biomarqueurs<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-blue\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Qualit\u00e9 &#038; conformit\u00e9 ax\u00e9es sur l\u2019aire th\u00e9rapeutique<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">SMQ adapt\u00e9 aux flux de travail cliniques selon le contexte th\u00e9rapeutique<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Gestion des risques sp\u00e9cifique \u00e0 l\u2019aire th\u00e9rapeutique<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Pr\u00e9paration aux audits et aux inspections dans les domaines de sp\u00e9cialit\u00e9<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Veille r\u00e9glementaire sur les mises \u00e0 jour des recommandations par indication<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                <\/div>\n                  \n          \n\n            <\/div>\n<\/section>\n\n\n\n<section id=\"block_3ba01cac2ad4dcb19fa99db7d11b4194\" class=\"case-study-details\" style=\"background-image: url(&#039;https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/testimonials-bg.jpg&#039;);\">\n    \n    \n    <div class=\"container\">\n                    <div class=\"headline\">\u00c9tudes de cas par aire th\u00e9rapeutique<\/div>\n        \n                    <div class=\"slider\">\n                                    <div class=\"slider-item\" data-button-url=\"https:\/\/mdxcro.com\/fr\/case-studies\/precision-medicine-cdx\/\">\n                                                <div class=\"subtitle\">Precision Medicine\/CDx<\/div>\n                                            <div class=\"list\">\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/challenge.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Challenge:<\/b><span style=\"font-weight: 400;\"> A US biotech developing an NGS-based CDx needed to conduct a performance study under IVDR to support both EU market access and pharma partnership requirements.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/solution.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Solution:<\/b><span style=\"font-weight: 400;\"> MDx designed an IVDR Annex XIV-compliant protocol with therapeutic-specific endpoints, managed sample collection across 9 oncology centers, and coordinated with laboratory sites for testing.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/result.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Result:<\/b><span style=\"font-weight: 400;\"> Successfully completed sample collection for 3 tumor types within 8 months, with full IVDR-compliant documentation and evidence package.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                <\/div>\n                    <\/div>\n                                    <div class=\"slider-item\" data-button-url=\"https:\/\/mdxcro.com\/fr\/case-studies\/infectious-disease\/\">\n                                                <div class=\"subtitle\">Infectious Disease<\/div>\n                                            <div class=\"list\">\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/challenge.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Challenge:<\/b><span style=\"font-weight: 400;\"> A global manufacturer needed to transition their molecular infectious disease assay from IVDD to IVDR with updated performance claims and expanded intended use.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/solution.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Solution:<\/b><span style=\"font-weight: 400;\"> MDx implemented a gap assessment, designed a clinical performance strategy compliant with IVDR, and managed sample collection across multiple European countries.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/result.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Result:<\/b><span style=\"font-weight: 400;\"> The client achieved IVDR certification with expanded clinical claims, strengthening their market position.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                <\/div>\n                    <\/div>\n                                    <div class=\"slider-item\" data-button-url=\"https:\/\/mdxcro.com\/fr\/case-studies\/genetic-testing\/\">\n                                                <div class=\"subtitle\">Genetic Testing<\/div>\n                                            <div class=\"list\">\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/challenge.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Challenge:<\/b><span style=\"font-weight: 400;\"> A US laboratory sought to CE mark their NGS clinical exome sequencing panel targeting over 4,000 genes under IVDR.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/solution.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Solution:<\/b><span style=\"font-weight: 400;\"> MDx developed complete technical documentation for the NGS workflow and bioinformatics pipeline, implemented ISO 13485 QMS, and managed the notified body submission process.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/result.svg\" alt=\"\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\">  <\/span>\n                                        <p><b>Result:<\/b><span style=\"font-weight: 400;\"> CE mark granted in 16 months, enabling the client to become one of the few laboratories globally to certify such a comprehensive gene panel under IVDR.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                <\/div>\n                    <\/div>\n                            <\/div>\n        \n        <div class=\"footer\">\n            <div class=\"slider-dots\"><\/div>\n            <div class=\"button-wrapper\">\n                <a href=\"\/resources\/?category=case-studies\" class=\"button button--tertiary\">Voir les \u00e9tudes de cas<\/a>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n<section class=\"table\"><div class=\"container\"><div class=\"headline\">Pourquoi choisir MDx ?<\/div><div class=\"table-wrapper\"><div class=\"feature-column-wrapper\"><table class=\"feature-table\"><thead><tr><th class=\"feature-column\">Capacit\u00e9<\/th><\/tr><\/thead><tbody><tr><td class=\"feature-cell\">\u00c9quipes sp\u00e9cialis\u00e9es par domaine<\/td><\/tr><tr><td class=\"feature-cell\">Protocoles adapt\u00e9s \u00e0 l\u2019indication<\/td><\/tr><tr><td class=\"feature-cell\">R\u00e9seaux de laboratoires sp\u00e9cialis\u00e9s &amp; de sites<\/td><\/tr><tr><td class=\"feature-cell\">Int\u00e9gration clinique\u2013r\u00e9glementaire\u2013conformit\u00e9<\/td><\/tr><tr><td class=\"feature-cell\">Veille r\u00e9glementaire en temps r\u00e9el<\/td><\/tr><tr><td class=\"feature-cell\">Exp\u00e9rience des maladies rares &amp; complexes<\/td><\/tr><\/tbody><\/table><\/div><div class=\"scrollable-columns-wrapper\"><table class=\"comparison-table\"><thead><tr><th class=\"column highlight\">MDx CRO<\/th><th class=\"column\">CRO typiques<\/th><\/tr><\/thead><tbody><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\"><\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">\u00c9quipes g\u00e9n\u00e9ralistes<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\"><\/td><td class=\"cell\"><img decoding=\"async\" width=\"22\" height=\"22\" class=\"wp-image-7062 icon\" style=\"width: 22px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/x-1.svg\" alt=\"\">Mod\u00e8les r\u00e9utilis\u00e9s d\u2019une \u00e9tude \u00e0 l\u2019autre<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\"><\/td><td class=\"cell\"><img decoding=\"async\" width=\"22\" height=\"22\" class=\"wp-image-7062 icon\" style=\"width: 22px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/x-1.svg\" alt=\"\">Couverture th\u00e9rapeutique limit\u00e9e<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\"><\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Expertise cloisonn\u00e9e<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\"><\/td><td class=\"cell\"><img decoding=\"async\" width=\"22\" height=\"22\" class=\"wp-image-7062 icon\" style=\"width: 22px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/x-1.svg\" alt=\"\">Mises \u00e0 jour peu fr\u00e9quentes<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\"><\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Exp\u00e9rience limit\u00e9e<\/td><\/tr><\/tbody><\/table><\/div><\/div><\/div><\/section>\n\n\n<section id=\"block_16b9d644d3f14be0378478128acccba2\" class=\"testimonials\" style=\"background-image: url(&#039;https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/testimonials-bg.jpg&#039;);\">\n        <div class=\"testimonials--bg\">\n      <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/testimonials-bg.jpg\" alt=\"\" \/>\n    <\/div>\n    <div class=\"container\">\n                    <div class=\"headline\">T\u00e9moignages clients<\/div>\n        \n                    <div class=\"slider\">\n                                    <div class=\"slider-item\">\n                                                    <p class=\"quote\">\u00ab\u00a0The therapeutic expertise MDx brings in oncology and CDx regulation was unmatched. Their insights significantly influenced our go-to-market strategy.\u00a0\u00bb<\/p>\n                                                                            <p class=\"author\">\n                                VP, Clinical Development                                                                <br>\n                                US-based Precision Medicine Company                                        \n                            <\/p>\n                                            <\/div>\n                                    <div class=\"slider-item\">\n                                                    <p class=\"quote\">\u00ab\u00a0MDx helped us meet aggressive timelines for IVDR performance studies while ensuring full data traceability and documentation integrity.\u00a0\u00bb<\/p>\n                                                                            <p class=\"author\">\n                                Director, Clinical Affairs                                                                <br>\n                                Global IVD Manufacturer                                        \n                            <\/p>\n                                            <\/div>\n                                    <div class=\"slider-item\">\n                                                    <p class=\"quote\">\u00ab\u00a0MDx\u2019s oncology expertise helped us navigate tissue-based CDx validation and secure multi-country study approvals under EU IVDR Annex XIV and US significant risk\u00a0\u00bb<\/p>\n                                                                            <p class=\"author\">\n                                Director Translational Medicine                                                                <br>\n                                Biotech                                        \n                            <\/p>\n                                            <\/div>\n                            <\/div>\n        \n        <div class=\"footer\">\n            <div class=\"slider-dots\"><\/div>\n            <div class=\"button-wrapper\">\n                            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n\n<section id=\"block_6a825c41c39b213e6a938f971ec29bec\" class=\"faqs\" style=\"padding-top: Par d\u00e9faut; padding-bottom: Par d\u00e9faut; margin-top: Par d\u00e9faut; margin-bottom: Par d\u00e9faut; \">\n    <div class=\"container\">\n    <div class=\"content\">\n      <div class=\"column\">\n                  <h2 class=\"headline\">T\u00e9moignages clients<\/h2>\n                          <a class=\"button button--quaternary\" href=\"https:\/\/mdxcro.com\/fr\/contact\/\" target=\"\">\n            Posez-nous une question          <\/a>\n              <\/div>\n      <div class=\"column\">\n                  <ul class=\"faq-list\">\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Comment MDx garantit-il l\u2019alignement th\u00e9rapeutique ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Nous affectons des experts sp\u00e9cifiques au domaine \u00e0 chaque projet, afin que votre \u00e9tude b\u00e9n\u00e9ficie d\u2019une solide exp\u00e9rience clinique et r\u00e9glementaire dans votre aire th\u00e9rapeutique.<\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">MDx peut-il accompagner les maladies rares ou des indications de niche ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Absolument. Nous avons l\u2019exp\u00e9rience des \u00e9tudes sur petites populations et des crit\u00e8res d\u2019inclusion complexes, notamment en p\u00e9diatrie, en stratification g\u00e9nomique et en validation de biomarqueurs rares. <\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Comment g\u00e9rez-vous les risques r\u00e9glementaires sp\u00e9cifiques \u00e0 l\u2019aire th\u00e9rapeutique ? <\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\"> Notre \u00e9quipe r\u00e9glementaire \u00e9labore des strat\u00e9gies sur mesure, align\u00e9es sur les recommandations, normes et \u00e9volutions de politiques propres \u00e0 l\u2019aire th\u00e9rapeutique.<\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Quelle est votre couverture mondiale des sites par aire th\u00e9rapeutique ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Nous maintenons des r\u00e9seaux de sites align\u00e9s sur les aires th\u00e9rapeutiques en Am\u00e9rique du Nord, dans l\u2019UE et en APAC, avec des relations \u00e9tablies pour chaque indication.<\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Comment MDx reste-t-il \u00e0 jour face \u00e0 l\u2019\u00e9volution des r\u00e9glementations ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Notre \u00e9quipe interne de veille r\u00e9glementaire suit en temps r\u00e9el l\u2019UE MDR\/IVDR, les recommandations de la FDA et les mises \u00e0 jour sp\u00e9cifiques \u00e0 chaque aire th\u00e9rapeutique.<\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                      <\/ul>\n              <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n\n  <script type=\"application\/ld+json\">\n    {\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Comment MDx garantit-il l\u2019alignement th\u00e9rapeutique ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nous affectons des experts sp\u00e9cifiques au domaine \u00e0 chaque projet, afin que votre \u00e9tude b\u00e9n\u00e9ficie d\u2019une solide exp\u00e9rience clinique et r\u00e9glementaire dans votre aire th\u00e9rapeutique.\"}},{\"@type\":\"Question\",\"name\":\"MDx peut-il accompagner les maladies rares ou des indications de niche ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Absolument. Nous avons l\u2019exp\u00e9rience des \u00e9tudes sur petites populations et des crit\u00e8res d\u2019inclusion complexes, notamment en p\u00e9diatrie, en stratification g\u00e9nomique et en validation de biomarqueurs rares.\"}},{\"@type\":\"Question\",\"name\":\"Comment g\u00e9rez-vous les risques r\u00e9glementaires sp\u00e9cifiques \u00e0 l\u2019aire th\u00e9rapeutique ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Notre \u00e9quipe r\u00e9glementaire \u00e9labore des strat\u00e9gies sur mesure, align\u00e9es sur les recommandations, normes et \u00e9volutions de politiques propres \u00e0 l\u2019aire th\u00e9rapeutique.\"}},{\"@type\":\"Question\",\"name\":\"Quelle est votre couverture mondiale des sites par aire th\u00e9rapeutique ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nous maintenons des r\u00e9seaux de sites align\u00e9s sur les aires th\u00e9rapeutiques en Am\u00e9rique du Nord, dans l\u2019UE et en APAC, avec des relations \u00e9tablies pour chaque indication.\"}},{\"@type\":\"Question\",\"name\":\"Comment MDx reste-t-il \u00e0 jour face \u00e0 l\u2019\u00e9volution des r\u00e9glementations ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Notre \u00e9quipe interne de veille r\u00e9glementaire suit en temps r\u00e9el l\u2019UE MDR\/IVDR, les recommandations de la FDA et les mises \u00e0 jour sp\u00e9cifiques \u00e0 chaque aire th\u00e9rapeutique.\"}}]}  <\/script>\n\n\n\n<section id=\"block_64d71087975dc1c572263cac632b856e\" class=\"call-to-action\" style=\"padding-top: Par d\u00e9faut; padding-bottom: Par d\u00e9faut; margin-top: Par d\u00e9faut; margin-bottom: Par d\u00e9faut; \">\n        <div class=\"call-to-action--bg\">\n      <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/mdx-cta-bg.png\" alt=\"\" \/>\n    <\/div>\n    <div class=\"container\">\n        <div class=\"grid\">\n            <div class=\"content\">\n                                    <h2 class=\"title\">Acc\u00e9l\u00e9rez votre \u00e9tude. R\u00e9duisez les risques de votre soumission. G\u00e9n\u00e9rez un impact clinique.   <\/h2>\n                \n                                    <div class=\"description wysiwyg\">\n                        <p><span style=\"font-weight: 400;\">Que vous fassiez progresser un CDx oncologique de nouvelle g\u00e9n\u00e9ration ou que vous lanciez un POCT respiratoire en Europe, MDx met \u00e0 votre disposition une expertise sp\u00e9cifique \u00e0 l\u2019aire th\u00e9rapeutique pour guider votre produit, du concept \u00e0 la certification.<\/span><\/p>\n                    <\/div>\n                            <\/div>\n\n                            <div class=\"button-wrapper\">\n                                                                        <a href=\"https:\/\/mdxcro.com\/fr\/contact\/?utm_source=terapeutic_areas\" class=\"button button--tertiary\" target=\"\">\n                                R\u00e9server un appel de d\u00e9couverte                            <\/a>\n                                                                                                <a href=\"https:\/\/mdxcro.com\/es\/servicios\/estudios-analiticos-ivd\/\" class=\"button button--secondary\" target=\"\">\n                                En savoir plus sur les \u00e9tudes IVDR                            <\/a>\n                                                            <\/div>\n                    <\/div>\n    <\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Pourquoi choisir MDx ? Capacit\u00e9 \u00c9quipes sp\u00e9cialis\u00e9es par domaine Protocoles adapt\u00e9s \u00e0 l\u2019indication R\u00e9seaux de laboratoires sp\u00e9cialis\u00e9s &amp; de sites Int\u00e9gration clinique\u2013r\u00e9glementaire\u2013conformit\u00e9 Veille r\u00e9glementaire en temps r\u00e9el Exp\u00e9rience des maladies rares &amp; complexes MDx CRO CRO typiques \u00c9quipes g\u00e9n\u00e9ralistes Mod\u00e8les r\u00e9utilis\u00e9s d\u2019une \u00e9tude \u00e0 l\u2019autre Couverture th\u00e9rapeutique limit\u00e9e Expertise cloisonn\u00e9e Mises \u00e0 jour peu fr\u00e9quentes [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-11367","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aires th\u00e9rapeutiques | CRO pour DM-IVD et dispositifs m\u00e9dicaux | MDx CRO<\/title>\n<meta name=\"description\" content=\"Plus de 50 investigations cliniques en oncologie, maladies infectieuses, cardiovasculaire, neurologie et plus encore : une expertise th\u00e9rapeutique DM-IVD et dispositifs m\u00e9dicaux chez MDx CRO.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aires th\u00e9rapeutiques | CRO pour DM-IVD et dispositifs m\u00e9dicaux | MDx CRO\" \/>\n<meta property=\"og:description\" content=\"Plus de 50 investigations cliniques en oncologie, maladies infectieuses, cardiovasculaire, neurologie et plus encore : une expertise th\u00e9rapeutique DM-IVD et dispositifs m\u00e9dicaux chez MDx CRO.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/\" \/>\n<meta property=\"og:site_name\" content=\"MDx CRO\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T12:16:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/domaines-therapeutiques\\\/\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/domaines-therapeutiques\\\/\",\"name\":\"Aires th\u00e9rapeutiques | CRO pour DM-IVD et dispositifs m\u00e9dicaux | MDx CRO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/domaines-therapeutiques\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/domaines-therapeutiques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/check-white-1.svg\",\"datePublished\":\"2025-07-30T07:33:41+00:00\",\"dateModified\":\"2026-07-23T12:16:26+00:00\",\"description\":\"Plus de 50 investigations cliniques en oncologie, maladies infectieuses, cardiovasculaire, neurologie et plus encore : une expertise th\u00e9rapeutique DM-IVD et dispositifs m\u00e9dicaux chez MDx CRO.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/domaines-therapeutiques\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mdxcro.com\\\/fr\\\/domaines-therapeutiques\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/domaines-therapeutiques\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/check-white-1.svg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/check-white-1.svg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/domaines-therapeutiques\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aires th\u00e9rapeutiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/\",\"name\":\"MDx CRO\",\"description\":\"MedTech &amp; IVD Clinical Research, Regulatory &amp; QA\",\"publisher\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#organization\"},\"alternateName\":\"MDx\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#organization\",\"name\":\"MDx CRO\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/MDX.svg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/MDX.svg\",\"width\":352,\"height\":114,\"caption\":\"MDx CRO\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/medtech-ivd-cro\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aires th\u00e9rapeutiques | CRO pour DM-IVD et dispositifs m\u00e9dicaux | MDx CRO","description":"Plus de 50 investigations cliniques en oncologie, maladies infectieuses, cardiovasculaire, neurologie et plus encore : une expertise th\u00e9rapeutique DM-IVD et dispositifs m\u00e9dicaux chez MDx CRO.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/","og_locale":"fr_FR","og_type":"article","og_title":"Aires th\u00e9rapeutiques | CRO pour DM-IVD et dispositifs m\u00e9dicaux | MDx CRO","og_description":"Plus de 50 investigations cliniques en oncologie, maladies infectieuses, cardiovasculaire, neurologie et plus encore : une expertise th\u00e9rapeutique DM-IVD et dispositifs m\u00e9dicaux chez MDx CRO.","og_url":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/","og_site_name":"MDx CRO","article_modified_time":"2026-07-23T12:16:26+00:00","og_image":[{"url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/","url":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/","name":"Aires th\u00e9rapeutiques | CRO pour DM-IVD et dispositifs m\u00e9dicaux | MDx CRO","isPartOf":{"@id":"https:\/\/mdxcro.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/#primaryimage"},"image":{"@id":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/#primaryimage"},"thumbnailUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg","datePublished":"2025-07-30T07:33:41+00:00","dateModified":"2026-07-23T12:16:26+00:00","description":"Plus de 50 investigations cliniques en oncologie, maladies infectieuses, cardiovasculaire, neurologie et plus encore : une expertise th\u00e9rapeutique DM-IVD et dispositifs m\u00e9dicaux chez MDx CRO.","breadcrumb":{"@id":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/#primaryimage","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg"},{"@type":"BreadcrumbList","@id":"https:\/\/mdxcro.com\/fr\/domaines-therapeutiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mdxcro.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Aires th\u00e9rapeutiques"}]},{"@type":"WebSite","@id":"https:\/\/mdxcro.com\/fr\/#website","url":"https:\/\/mdxcro.com\/fr\/","name":"MDx CRO","description":"MedTech &amp; IVD Clinical Research, Regulatory &amp; QA","publisher":{"@id":"https:\/\/mdxcro.com\/fr\/#organization"},"alternateName":"MDx","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mdxcro.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/mdxcro.com\/fr\/#organization","name":"MDx CRO","url":"https:\/\/mdxcro.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mdxcro.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg","width":352,"height":114,"caption":"MDx CRO"},"image":{"@id":"https:\/\/mdxcro.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/medtech-ivd-cro"]}]}},"_links":{"self":[{"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/pages\/11367","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/comments?post=11367"}],"version-history":[{"count":8,"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/pages\/11367\/revisions"}],"predecessor-version":[{"id":12219,"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/pages\/11367\/revisions\/12219"}],"wp:attachment":[{"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/media?parent=11367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}